tildrakizumab
ItalyDrugs containing this active substance
-
Ilumetri is used for the treatment of moderate-to-severe plaque psoriasis in adults, helping to improve skin appearance and reduce symptoms.
Form: solution for injection
Active substance Dosage tildrakizumab - ATC: L04AC17
Manufacturer: ALMIRALL S.A.